HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arachidonic acid and the brain.

Abstract
Kinetic methods in unanesthetized rodents have shown that turnover rates of arachidonic acid (AA) and docosahexaenoic acid (DHA) in brain membrane phospholipids are rapid and energy consuming and that phospholipase A(2) (PLA(2)) and acyl-CoA synthetase enzymes that regulate turnover are specific for one or the other PUFA. Thus, AA turnover in brain phospholipids was reduced, and AA-selective cytosolic cPLA(2) or acyl-CoA synthetase, as well as cyclooxygenase (COX)-2, were downregulated in brains of rats given drugs effective against bipolar disorder, whereas DHA turnover and expression of DHA-selective calcium-independent iPLA(2) were unchanged. Additionally, the brain AA and DHA cascades can be altered reciprocally by dietary or genetic conditions. Thus, following 15 wk of dietary (n-3) PUFA deprivation, DHA loss from rat brain was slowed because of reduced iPLA(2) and COX-1 expression, whereas AA-selective cPLA(2), sPLA(2), and COX-2 were upregulated, as were AA and docosapentaenoic acid concentrations. Measured rates of AA and DHA incorporation into brain represent their respective rates of metabolic consumption, because these PUFA are not synthesized de novo or converted significantly from their precursors in brain. In healthy human volunteers, positron emission tomography (PET) was used to show that the brain consumes AA and DHA at respective rates of 17.8 and 4.6 mg/d, whereas in patients with Alzheimer disease, AA consumption is elevated. In the future, PET could be used to relate human brain rates of AA and DHA consumption to liver PUFA metabolism and dietary PUFA intake.
AuthorsStanley I Rapoport
JournalThe Journal of nutrition (J Nutr) Vol. 138 Issue 12 Pg. 2515-20 (Dec 2008) ISSN: 1541-6100 [Electronic] United States
PMID19022981 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Antimanic Agents
  • Fatty Acids, Omega-3
  • Docosahexaenoic Acids
  • Arachidonic Acid
  • Lithium
  • Phospholipases A2
Topics
  • Animals
  • Antimanic Agents (administration & dosage)
  • Arachidonic Acid (metabolism)
  • Brain (diagnostic imaging, drug effects, metabolism)
  • Docosahexaenoic Acids (metabolism)
  • Fatty Acids, Omega-3 (administration & dosage)
  • Humans
  • Kinetics
  • Lithium (administration & dosage)
  • Models, Neurological
  • Phospholipases A2 (metabolism)
  • Positron-Emission Tomography
  • Rats
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: